-
1دورية أكاديمية
المؤلفون: Molina, Ana M.1 amm9052@med.cornell.edu, Hutson, Thomas E.2 Thomas.Hutson@USONCOLOGY.COM, Nosov, Dmitry3 nosov@mail.ru, Tomczak, Piotr4 piotr.tomczak@skpp.edu.pl, Lipatov, Oleg5 lipatovoleg@bk.ru, Sternberg, Cora N.6 cnsternberg@corasternberg.com, Motzer, Robert7 motzerr@mskcc.org, Eisen, Tim8 tgqe2@medschl.cam.ac.uk
المصدر: European Journal of Cancer. May2018, Vol. 94, p87-94. 8p.
مصطلحات موضوعية: *ANTINEOPLASTIC agents, *CLINICAL trials, *CROSSOVER trials, *METASTASIS, *HEALTH outcome assessment, *RENAL cell carcinoma, *PROTEIN-tyrosine kinase inhibitors, *VASCULAR endothelial growth factors, *TREATMENT effectiveness, *DESCRIPTIVE statistics, *SORAFENIB
-
2دورية أكاديمية
المؤلفون: Hutson, Thomas E.1 thomas.hutson@usoncology.com, Bellmunt, Joaquim2, Porta, Camillo3, Szczylik, Cezary4, Staehler, Michael5, Nadel, Andrea6, Anderson, Sibyl7, Bukowski, Ronald8, Eisen, Tim9, Escudier, Bernard10 escudier@igr.fr
المصدر: European Journal of Cancer. Sep2010, Vol. 46 Issue 13, p2432-2440. 9p.
مصطلحات موضوعية: *PROTEIN-tyrosine kinase inhibitors, *RENAL cell carcinoma, *DRUG side effects, *RETROSPECTIVE studies, *PREVENTIVE medicine, *RENAL cancer patients, *EVALUATION of clinical trials, *ANTINEOPLASTIC agents, *CANCER patients, *MEDICAL care, *EVALUATION of medical care, *MEDICAL needs assessment, *PATIENTS, *SAFETY, *DIAGNOSIS